Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

MAID is currently legal in 10 states and Washington, D.C., but eight other states are considering similar laws this year.

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

The genes included those involved in the function of energy-producing mitochondria, lipid and iron metabolism, and the ...

Lifearc has announced a collaboration with Neuropeutics Inc. to develop a new small molecule for the treatment of motor neuron disease (MND), or amyotrophic lateral sclerosis (ALS). Neuropeutics and ...